Alnylam Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.

CEO

Yvonne L. Greenstreet

CEOYvonne L. Greenstreet

Employees

2,230

Employees2,230

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2002

Founded2002

Employees

2,230

Employees2,230

ALNY Key Statistics

Market cap

40.74B

Market cap40.74B

Price-Earnings ratio

-149.23

Price-Earnings ratio-149.23

Dividend yield

—

Dividend yield—

Average volume

681.67K

Average volume681.67K

High today

$317.54

High today$317.54

Low today

$306.70

Low today$306.70

Open price

$306.70

Open price$306.70

Volume

953.94K

Volume953.94K

52 Week high

$317.54

52 Week high$317.54

52 Week low

$153.23

52 Week low$153.23

ALNY News

Simply Wall St 12h

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth Phase

recently announced the appointment of Dr. Pushkal Garg as Executive Vice President and Chief Research and Development Officer to accelerate its R&D efforts. Thi...

Analyst ratings

71%

of 34 ratings

Buy

70.6%

Hold

26.5%

Sell

2.9%

People also own

Based on the portfolios of people who own ALNY. This list is generated using Robinhood data, and it’s not a recommendation.

Vertex Pharmaceuticals

Taiwan Semiconductor Manu…